1130156-52-3

Basic information

• Product Name: 7-[(2E)-4-bromobut-2-enoyl]-N-(3,4-dichlorophenyl)-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amine
• Synonyms: 7-[(2E)-4-bromobut-2-enoyl]-N-(3,4-dichlorophenyl)-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amine
• CAS NO: 1130156-52-3
• Molecular Weight: 498.23
• Mol File: 1130156-52-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 7-[(2E)-4-bromobut-2-enoyl]-N-(3,4-dichlorophenyl)-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 7-[(2E)-4-bromobut-2-enoyl]-N-(3,4-dichlorophenyl)-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amine(1130156-52-3)
• EPA Substance Registry System: 7-[(2E)-4-bromobut-2-enoyl]-N-(3,4-dichlorophenyl)-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amine(1130156-52-3)

Safety Data

• Hazardous Substances Data: 1130156-52-3(Hazardous Substances Data)

Upstream product

• 13991-36-1 4-bromocrotonic acid 
• 951035-47-5 N-(3,4-dichlorophenyl)-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amine 

Downstream Products

• 1130153-20-6 N-(3,4-dichlorophenyl)-7-[(2E)-4-(4-pyridin-2-ylpiperazin-1-yl)but-2-enoyl]-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amine 
• 1130153-21-7 N-(3,4-dichlorophenyl)-7-[(2E)-4-(1-methylhexahydropyrrolo[3,4-b]pyrrol-5(1H)-yl)but-2-enoyl]-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amine 
• 1130153-18-2 7-[(2E)-4-azetidin-1-ylbut-2-enoyl]-N-(3,4-dichlorophenyl)-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amine 
• 1130153-19-3 N-(3,4-dichlorophenyl)-7-[(2E)-4-(1,4-oxazepan-4-yl)but-2-enoyl]-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-amine 

Relevant articles and documents

SUBSTITUTED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF

This invention relates to novel compounds and processes for their preparation, methods of treating diseases, particularly cancer, comprising administering said compounds, and methods of making pharmaceutical compositions for the treatment or prevention of disorders, particularly cancer.